BIO stock · SAM stock

BIO vs SAM · rev $2.58B vs rev $2.01B

BIO (BIO) versus Boston Beer Company Inc (SAM) — a side-by-side from cached financials, not a winner call.

BIO (BIO) common stock.

Boston Beer Company Inc (SAM) is a beverages - brewers company listed on NYSE.

Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.

Latest reported SAM revenue for 2024-12-28 was $2.01B. Net income was $59.7M. Revenue was up 0.2% from 2023-12-30 to 2024-12-28. SAM currently screens at market cap $1.79B.

BIO currently screens at market cap $0. SAM currently screens at market cap $1.79B.

Not investment advice. Open the BIO and SAM stock pages for the full models.

Not investment advice.

Popular Stock Comparisons